These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 20048712)

  • 21. Daily dosing of highly active antiretroviral therapy.
    Rosenbach KA; Allison R; Nadler JP
    Clin Infect Dis; 2002 Mar; 34(5):686-92. PubMed ID: 11823957
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Impact of a modified directly administered antiretroviral treatment intervention on virological outcome in HIV-infected patients treated in Burkina Faso and Mali.
    Pirkle CM; Boileau C; Nguyen VK; Machouf N; Ag-Aboubacrine S; Niamba PA; Drabo J; Koala S; Tremblay C; Rashed S
    HIV Med; 2009 Mar; 10(3):152-6. PubMed ID: 19245536
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Sequencing of antiretroviral therapy in children in low- and middle-income countries.
    Sohn AH; Nuttall JJ; Zhang F
    Curr Opin HIV AIDS; 2010 Jan; 5(1):54-60. PubMed ID: 20046148
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Construction, training and clinical validation of an interpretation system for genotypic HIV-1 drug resistance based on fuzzy rules revised by virological outcomes.
    De Luca A; Vendittelli M; Baldini F; Di Giambenedetto S; Trotta MP; Cingolani A; Bacarelli A; Gori C; Perno CF; Antinori A; Ulivi G
    Antivir Ther; 2004 Aug; 9(4):583-93. PubMed ID: 15456090
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effectiveness of highly active antiretroviral therapy in HIV-positive children: evaluation at 12 months in a routine program in Cambodia.
    Janssens B; Raleigh B; Soeung S; Akao K; Te V; Gupta J; Vun MC; Ford N; Nouhin J; Nerrienet E
    Pediatrics; 2007 Nov; 120(5):e1134-40. PubMed ID: 17954553
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The World Health Organization's global strategy for prevention and assessment of HIV drug resistance.
    Bennett DE; Bertagnolio S; Sutherland D; Gilks CF
    Antivir Ther; 2008; 13 Suppl 2():1-13. PubMed ID: 18578063
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Changes over time in risk of initial virological failure of combination antiretroviral therapy: a multicohort analysis, 1996 to 2002.
    Lampe FC; Gatell JM; Staszewski S; Johnson MA; Pradier C; Gill MJ; de Lazzari E; Dauer B; Youle M; Fontas E; Krentz HB; Phillips AN
    Arch Intern Med; 2006 Mar; 166(5):521-8. PubMed ID: 16534038
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Conservation of first-line antiretroviral treatment regimen where therapeutic options are limited.
    Orrell C; Harling G; Lawn SD; Kaplan R; McNally M; Bekker LG; Wood R
    Antivir Ther; 2007; 12(1):83-8. PubMed ID: 17503751
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Strategies to optimize HIV treatment outcomes in resource-limited settings.
    Nakanjako D; Colebunders R; Coutinho AG; Kamya MR
    AIDS Rev; 2009; 11(4):179-89. PubMed ID: 19940945
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Resistance profiles and adherence at primary virological failure in three different highly active antiretroviral therapy regimens: analysis of failure rates in a randomized study.
    Røge BT; Barfod TS; Kirk O; Katzenstein TL; Obel N; Nielsen H; Pedersen C; Mathiesen LR; Lundgren JD; Gerstoft J
    HIV Med; 2004 Sep; 5(5):344-51. PubMed ID: 15369509
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Detection of HIV drug resistance during antiretroviral treatment and clinical progression in a large European cohort study.
    Cozzi-Lepri A; Phillips AN; Clotet B; Mocroft A; Ruiz L; Kirk O; Lazzarin A; Wiercinska-Drapalo A; Karlsson A; Lundgren JD;
    AIDS; 2008 Oct; 22(16):2187-98. PubMed ID: 18832882
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Diagnosis of antiretroviral therapy failure in Malawi: poor performance of clinical and immunological WHO criteria.
    van Oosterhout JJ; Brown L; Weigel R; Kumwenda JJ; Mzinganjira D; Saukila N; Mhango B; Hartung T; Phiri S; Hosseinipour MC
    Trop Med Int Health; 2009 Aug; 14(8):856-61. PubMed ID: 19552661
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Multidrug resistance: a clinical approach.
    Yazdanpanah Y
    Curr Opin HIV AIDS; 2009 Nov; 4(6):499-506. PubMed ID: 20048717
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Adherence to antiretroviral therapy: the more you look, the more you see.
    Taiwo B
    Curr Opin HIV AIDS; 2009 Nov; 4(6):488-92. PubMed ID: 20048715
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Investigational agents for salvage.
    Pozniak AL
    Curr Opin HIV AIDS; 2009 Nov; 4(6):524-30. PubMed ID: 20048721
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Antiretroviral therapy: treatment-experienced individuals.
    Calvo KR; Daar ES
    Infect Dis Clin North Am; 2014 Sep; 28(3):439-56. PubMed ID: 25151565
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Reductions in virological failure and drug resistance in Chinese antiretroviral-treated patients due to lamivudine-based regimens, 2003-12.
    Xing H; Ruan Y; Hsi JH; Kan W; Liao L; Leng X; Wang J; He C; Shao Y;
    J Antimicrob Chemother; 2015 Jul; 70(7):2097-103. PubMed ID: 25855758
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Advances in antiretroviral therapy.
    Taylor B; Olender S; Wilkin TJ; Hammer SM
    Top Antivir Med; 2011; 19(2):69-97. PubMed ID: 21868824
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Recent advances in antiretroviral drugs.
    Ghosh RK; Ghosh SM; Chawla S
    Expert Opin Pharmacother; 2011 Jan; 12(1):31-46. PubMed ID: 20698725
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Resistance to antiretroviral therapy].
    Alberdi Leniz A; Tuset Creus M; Martín Conde M; del Cacho del Cacho E; Nigorra Caro M; Codina Jané C; Ribas I Sala J
    Farm Hosp; 2004; 28(6 Suppl 1):55-71. PubMed ID: 15649117
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.